Cloud Banner

Press Release

Jan, 02 2023

Dow, Roquette Frères and Evonik Industries AG dominated the North America Pharmaceutical Excipients Market in 2021

The North America Pharmaceutical Excipients Market is expected to grow with a CAGR of 6.6% in the forecast period of 2022 to 2029. The years considered for the study are as mentioned below.

Access Full Report @

The North America pharmaceutical excipients market is a highly consolidated market, which includes a specific number of key players. The market has witnessed increased strategic developments owing to favorable market scenarios.   

The major players operating in the market are introducing a strong range of healthcare information technology (IT) services and software and adopting strategic initiatives such as acquisition and agreement into the market. This helped companies to maximize sales with an enhanced services portfolio.

Dow is the market leader in the market. The other players in this market are Kerry Group plc., DFE Pharma, Cargill, Incorporated, Pfanstiehl, Colorcon, MEGGLE GmbH & Co. KG, Omya AG, Peter Greven GmbH & Co. KG, Ashland., Evonik, Croda International Plc, Roquette Frères., The Lubrizol Corporation, BASF SE, Avantor, Inc., BENEO, Chemie Trade, among others.


Dow is headquartered in Michigan, U.S. and was founded in 1897. The company focuses on delivering a sustainable future for the world through our materials science expertise and collaboration with partners.

The company provides product categories  in Additives and Modifiers, Adhesives and Sealants, Amines and Chelates, Conductive Materials, Elastomers and Plastomers, Foam Control Agents, Gels, Encapsulants and Conformal Coatings, Intermediates and Feedstocks, Lubricants, Heat Transfer and Deicing Fluids, Monomers, Optical Materials, Plastic Additives, Polyethylene, Polyurethanes, Release Coatings and Agents, Resins, Binders and Film Formers, Silicones, Silicone-Organic Hybrids and Silanes, Solvents and Glycols, Specialty Polymers and Compounds, Surfactants Emulsifiers and Polyglycols.

The company has around 35,700 employees. The company has its subsidiaries, which are Dow Chemical (Australia) Limited (Australia), Dow Chemical Pacific Limited (Hong Kong), Dow Chemical Pacific (Singapore) Private Limited (Singapore), Dow Chemical International Pvt. Ltd (India), among others.

For instance,

  • In September 2022, Dow launched DOWSIL Immersion Cooling Technology, a next-generation solution for cooling hyper-scale cloud and enterprise data centers with optimized efficiency and sustainability. It offers a revolutionary approach to thermal management and sustainability for fast-growing data centers in a new era of high-speed, high-volume data communications. This has helped the company to expand its product portfolio. workloads running in Oracle Cloud. The new five-year deal will build on AT&T’s use of Oracle Fusion Cloud Enterprise Resource Planning (ERP), Oracle Fusion Cloud Customer Experience (CX), Oracle Cloud Infrastructure, and other Oracle Cloud services.

The company has a wide presence across Europe, Asia Pacific, Americas, the Middle East & Africa.

 Roquette Frères.

Roquette Frères. is headquartered in Hauts-de-France, France and was founded in 1933. The company focuses on providing pharmaceutical excipients products and services. The company has BioPharma, Pharma & Nutraceuticals, Cosmetics, Food & Nutrition, Animal Nutrition, and Industrial Markets as product categories.

 For instance,

  • In December 2017, Roquette Frères. It partnered with Itacel, a leading player in the pharmaceutical excipients market in Brazil and Latin America. This has offered Roquette excipient for oral dosages in pharmaceutical and nutraceutical applications. This has helped the company to expand its business.

The company has a wide presence in Europe, Asia Pacific, and North America. The subsidiaries are present in the company. Roquette GmbH (Germany), Roquette Beijing (China), Sethness-Roquette India Ltd. (India), among others.

North America Pharmaceutical Excipients Market


Evonik was founded in 2007  and is headquartered in North Rhine–Westphalia Land, Germany. The company focuses on providing high-quality products and services in pharma & healthcare, food & beverages, personal care, general industry, agriculture and among others. The company provides business segments such as specialty additives, nutrition & care, smart materials, performance materials, technology & infrastructure.

The performance materials are market focused segment. The company provides various product categories, such as drug delivery, biopharma, nutrition, and medical devices. Healthcare IT is the market-focused category.

The company has a wide presence in Europe, Asia Pacific, North America, Middle East & Africa. It has various subsidiaries like Evonik Functional Solutions GmbH  (Germany), Evonik Advanced Botanicals S.A.S. (France), Evonik Chemicals Ltd. (UK), Evonik India Pvt. Ltd. (India), among others.

For instance,

  • In May 2022, Evonik launched the EUDRACAP platform of easy-to-handle capsules to help the pharmaceutical industry accelerate the speed to market for complex oral drug products in the early development stages. EUDRACAP enteric is the first product of the platform to become commercially available. This enteric-coated pre-locked capsule gives pharmaceutical companies access to a capsule that can optimize gastric resistance, boost intestinal absorption, and enhance bioavailability. This has helped the company to increase its revenue.

Client Testimonials